Aug 21, 2023 / 03:00PM GMT
Operator
Good afternoon and welcome to the Kintara Therapeutics key opinion leader event. (Operator Instructions) As a reminder, today's call will be recorded and a replay will be made available on the Kintara Therapeutics' website following the conclusion of the event.
With that, I would like to turn the call over to your host, Chief Executive Officer of Kintara Therapeutics, Robert Hoffman. Please go ahead, Robert.
Robert Hoffman - Kintara Therapeutics, Inc. - President, CEO, CFO and Chairman of the Board
Thank you, Sarah, and welcome, everyone. Thank you for attending our key opinion leader. We're really excited to have Dr. Wen and Dr. de Groot to give a short presentation and answer any questions that you have.
Next slide. Here's the agenda. I'll give a brief introduction. Dr. de Groot will go through the unmet medical need in glioblastoma or GBM. Dr. Wen will explore the treatment landscape and VAL-083's potential role, if approved. Dennis Brown, our Chief Scientific Officer, will go through the scientific rationale and mechanism of action of VAL
Kintara Therapeutics Inc to Host KOL Event (Virtual) Transcript
Aug 21, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers